Although ERK1/2 signaling is mostly involved in pro-survival mechanisms (in both CRC and other cell types), the authors also report that inhibition of MEK1/2 using the U0126 inhibitor, reversed the effects of 6-MSITC [103]. The gene discussed is MAPK3; the disease is colorectal carcinoma.